RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $241,000 | -45.8% | 24,911 | 0.0% | 0.03% | -50.0% |
| Q3 2021 | $445,000 | -26.8% | 24,911 | 0.0% | 0.06% | -34.9% |
| Q2 2021 | $608,000 | -7.9% | 24,911 | 0.0% | 0.09% | -13.1% |
| Q1 2021 | $660,000 | -2.1% | 24,911 | -71.9% | 0.10% | -36.9% |
| Q4 2020 | $674,000 | – | 88,740 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |